H34.00
Transient retinal artery occlusion, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Transient retinal artery occlusion (TRAO) is a temporary blockage of blood flow to the retina, which can cause sudden vision changes. It affects the eye's retina, the light-sensitive tissue responsible for converting visual information into nerve signals sent to the brain. Although the blockage is temporary, the event signals potential underlying health issues that require attention to prevent future, more severe eye problems or vision loss.
Causes & Symptoms
Clinical Causes: Emboli or blood clots traveling from other parts of the body, such as the heart or large arteries Degenerative changes in blood vessels leading to narrowing or narrowing of arteries (atherosclerosis) Blood vessel spasms that temporarily restrict blood flow Cardiovascular conditions like atrial fibrillation or heart valve disease High blood pressure damaging blood vessel walls Diabetes mellitus leading to blood vessel damage Blood viscosity issues or clotting disorders
Key Symptoms: Sudden, painless loss of vision in one eye Brief episodes of visual disturbance, such as partial vision loss or visual dimming Transient visual obscurations that resolve within minutes Possible visual field defects depending on the affected area in the retina
Diagnostic & Treatment
Diagnosis Path: Diagnosing transient retinal artery occlusion involves a comprehensive eye examination and medical assessment. Health professionals may perform:
Treatment Protocols: While transient retinal artery occlusion often resolves on its own, treatment focuses on addressing underlying causes and preventing future events. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H34.00 a billable ICD-10 code?
Yes, H34.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H34.00?
Clinical documentation must specify the nature of Transient retinal artery occlusion, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference